Clinical translation and implementation of technological innovations can significantly improve diagnostics and treatment.

The care for our patients becomes more complex, since they suffer more and more from several diseases next to their musculoskeletal disorder. We address this by investigating innovative methods for diagnostics and treatment.

Our research aims to:

  • Investigate innovative methods for diagnostics and treatment
  • Provide evidence for most optimal treatment options
Relevance

How our research benefits to society

Innovative methods for diagnostics and treatment are needed to further improve orthopaedic treatment for our patients.

  • The number and complexity of our patients are rising. Therefore, our research group investigates innovative imaging techniques, risk predictions, tools to support surgical decision making and advanced 3D techniques to develop innovative methods for diagnostics and treatment. Artificial Intelligence, Machine Learning and Deep learning as well as, innovative technologies using tracers that make tumors and infections visible that could not be imaged until now. This research is carried out in a large international network including Boston, Austin, Adelaide, Newcastle, Hong Kong.

  • Prolonged wound leakage after primary Total Knee or Hip Arthroplasty (TKA/THA) is associated with prosthetic joint infection (PJI) and can be treated by both non-surgical and surgical treatment. Until now, literature provides no evidence on the superiority of either treatment and the optimal timing of surgical treatment.

    The LEAK study is an international multicenter randomised controlled trial which aims to compare the clinical effectiveness, cost effectiveness and impact on quality of life of early surgical treatment (DAIR at day 9 to 10 after index surgery) with non-surgical treatment in patients with prolonged wound leakage after primary TKA/THA.

Contact

Els Jilleba Secretary of the department of Orthopedics